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Abstract 
Predicting the recurrence of non-small cell lung cancer remains a clinical challenge. The current best practice employs heuristic 
decisions based on the TNM classification scheme that many believe can be improved upon. Much research has recently been 
devoted to searching for gene signatures derived from gene expression microarrays for this challenge, but a consensus signature 
is still elusive. We present an approach to first create a benchmark for recurrence prediction based only upon gender, age and 
TNM features that uses several learning classifier induction methods and combines them into an ensemble using a recent 
extension of the general regression neural network. Using this approach on a pooled sample of 422 patients from two previously 
published studies (Shedden and Raponi), we demonstrate error rates in the low 20% for both false positives and negatives. Future 
work will focus on discovering if gene signatures can be discovered that can improve this performance. 
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1. Background 
Lung cancer is the leading cause of death in cancer patients worldwide. In 2011, the American Cancer Society 
predicted that 156,940 people would fall victim to the disease, accounting for 27% of all cancer deaths [1]. Of the 
221,130 estimated cases that would be diagnosed in 2011, 85% would have late stage tumors (II, III, IV) that have 
begun to advance. Due primarily to this late stage diagnosis, the 5-year survival rate of lung cancer patients is 16%. 
For these patients, treatment often includes surgical resection of tumors if possible, post-operative radiation, and 
adjuvant chemotherapy. The 5-year survival rate for early stage (I) non-small cell lung cancer (NSCLC) patients is 
53% [1] and treatment at this stage often only includes surgical resection [2]. However, 35%-50% of these patients 
will suffer a relapse of the disease within 5 years of surgery [5]. As a result, many doctors resort to administering 
post-operative chemotherapy, which in most cases improves survival, but this approach is controversial, expensive, 
and may not be necessary for all patients. Doctors currently lack a validated and clinically accepted method to 
predict which patients are at a high risk of recurring cancer [4]. Those patients that are at a high risk of recurrence 
might benefit from post-operative adjuvant chemotherapy, whereas those patients that are at a low risk can be spared 
the side effects of chemotherapy [5]. Much research is currently focused on discovering gene expression signatures 
that seek to improve our ability to identify patients at high risk of recurrence [6].  The work reported in this paper is 
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a first step in this direction by determining how well methods based on statistical learning theory can do when given 
only simple demographic and TNM (Tumor, Node, Metastasis) features in a data set that combines information from 
two publically available investigations of non-small cell lung cancer [3, 5]. With this as a benchmark, future work 
will investigate to what extent gene expression information can further improve recurrence prediction. 
2.  Methods 
2.1 Data Set 
 
The data set consisted of 422 patients drawn from two publically available NSCLC studies: Raponi et al. [3] 
(n=130) and Shedden et al. [5] (n=292). Work is on-going to compile and pool the microarray data from these 
studies with the aim of searching for robust gene signatures, but herein we explore only demographic and TNM 
(Tumor, lymph Node, Metastases) features. The features comprised gender, age, tumor stage (IA, IB, IIA, IIB, IIIA, 
IIIB), cancer type (adenocarcinoma, squamous cell), tumor size (grade 0-4), lymph node involvement (grade 0-3), 
metastasis (y/n), and stage grouping (codes 0-3). The outcome measure to be predicted was good prognosis 
(recurrence or death > 36 months) or poor prognosis  36 months). All categorical variables were mapped linearly 
to the range [0,1], while age was mapped using the tanh (hyperbolic tangent) function setting the minimum age in 
the data to 0.1 and the maximum to 0.9. 
 
We broke the data set into five folds stratified so that each fold contained roughly equal proportions of both 
cancer cell types and prognosis categories. Each classifier induction method (see below) was applied to each set of 
four folds and tested on the fifth. The resulting predictions on the left-out fold were concatenated and compared to 
the ground truth prognosis to compute an AUC (area under the ROC: receiver operator characteristic curve) and 
errors. Finally, we use the Generalized Regression Neural Networks (GRNN) “oracle” to combine the three 
classifiers into an ensemble. 
 
2.2 Linear Regression 
 
We used the R system (version 2.13.0), linear regression of the independent variables against “prognosis”.  
 
2.3 Support Vector Machine (SVM) 
 
The support vector machine (SVM) that was used was the libsvm learner in Orange [7,8]. A simple grid search 
was done to find the best performing parameters and the kernel that was used in the SVM was the radial basis 
function with a gamma value of 0.00010. This value gave well performing SVMs for all five folds. 
2.4 Probabilistic Neural Network (PNN) 
The PNN is a classifier that makes very effective use of the shapes of population distributions.  Given a sample/ 
case/control that has previously not been classified, the PNN determines the probability that the point belongs to a 
particular class based on populations of points whose class identity is known a priori.  The PNN makes this 
determination in two steps.  
It uses the multivariate Parzen density estimator to estimate (a constant multiple of) the density function of each 
population at the known point.  Then it computes the Bayesian posterior probability of membership in each 
population and assigns the unknown to the class having the highest posterior probability.  In particular, suppose we 
have a training set composed of n cases.  Each case i (i=1, …, n) consists of: 
xi,j  j=1, …, p 
 
These predictor variables determine the relative efficacy of the prediction models.  The observed values of the 
predictor variables for the unknown case are: 
xj  j=1, …, p 
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These are the values of the observed gate variables.  The weighted Euclidean distance function is often employed: 
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The (unnormalized) density function is then given by Parzen's formula: 
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The above procedure is repeated for each of the K classes, giving the unnormalized density gk(x) for k=1, …, K.  
The Bayesian probability that the unknown case was drawn from class k is as follows: 
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From the above formulation, the PNN has three interesting properties.  First, under reasonable assumptions, and as 
the training set size increases, the PNN is an asymptotically optimal classifier.  Second, the PNN is fully nonlinear.  
It does not impose constraints of linearity on the model (as does ordinary discriminate analysis), nor does it require 
linear separability like many other classifiers.  Finally, the PNN has the ability to compute Bayesian probabilities 
(including the use of priors if desired), which is a great advantage in many practical applications. 
 
2.5 GRNN Ensemble Formulation Summary  
 
The objective is to design an ensemble processor that uses the gate variables to intelligently combine the outputs of 
the competing models [9]. A background and history of ensemble processing may be found in Land et al. [10]. Once 
the expected error of each prediction model is estimated, these expected errors are used to compute the weights for 
each model. When an unknown case is processed, the gate variables are used by the GRNN to decide which models 
are likely to be best for this particular case. These models are weighted more heavily than the likely inferior models. 
In particular, one has a training set composed of n cases. Each case i (i =1, …, n) consists of p gate variables: xi,j 
where j =1, …, p. These gate variables determine in some way the relative efficacy of the prediction models. The m 
competing prediction models provide outputs qi,k for each case i where k =1, …, m. The desired output (the target 
value) for case i is yi. 
 
For the gate variables and model outputs of a trial case that is to be evaluated, just one subscript is used : xj where j 
=1, …, p, are the values of the observed gate variables, and qk where k=1, …, m, are the computed outputs from the 
m competing prediction models for this new case. 
 
Define the weighted Euclidean distance (as determined by the gate variables) between training case, i, and the trial 
case. Then the GRNN oracle’s predicted squared error for model k may be shown to be:  
                                                 (4) 
 
It is desired that the final prediction be a linear combination of the outputs of the competing models:  
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                                                                                            (5) 
Here wk are the weights for the outputs. If the models have the (desirable) property that their predictions are 
unbiased, then the following condition is imposed: 
                                                                                             (6) 
The linear combination of unbiased estimators having minimum mean-squared error uses weights proportional to 
the reciprocal of each estimator’s variance. If the predicted squared error is used in place of the variance, the 
following formula is derived for the weights: 
 
                                                                               (7) 
 
The GRNN ensemble processor is trained (i.e., the p sigma weights in the weighted Euclidean distance in (1) are 
optimized) in the leave-one-out validation manner. Differential evolution [11] was used to optimize the sigma 
weights over the set of training cases. 
3. Results  
Table 1 shows the correlations among the predictions made by each classifier among the 422 cases. The modest 
correlations with the ground truth (prognosis class) and the generally modest correlations among the classifier 
predictions, suggest that the GRNN oracle might be able to learn an ensemble classifier that would do better than 
any of the three alone. 
 
Table 1. Correlations among classifier predictions and the ground truth 
 
 Regression SVM PNN prognosis 
Regression 1    
SVM 0.911 1   
PNN 0.700 0.701 1  
Prognosis 0.607 0.564 0.488  1 
 
Table 2 shows the AUC (area under the ROC curve) and error counts for false positives (FP) and false negatives 
(FN) using a threshold of 0.5 (i.e. any prediction above 0.5 is called a positive, below a negative classification). The 
ensemble’s error rates (Table 2) coincide with the SVM’s because the SVM tends to create a substantial gap 
between the positive and negative classes, and so is least sensitive among the chosen classifiers to the choice of 
threshold. Perhaps curiously, the SVM also yielded the worst AUC. 
 
Table 2.  Results from 5-fold cross validation of individual classifier and the ensemble 
 
Classifier AUC test CV errors FP 
Test set 
CV errors FN 
Test set 
CV total errors 
Regression 0.830  50/177 28.2%   39/245 15.9%   89/422 21.1% 
SVM 0.783  38/177 21.5%   55/245 22.4%   93/422 22.0% 
PNN 0.822  22/177 12.4% 116/245 47.3% 138/422 32.7% 
GRNN 0.847  38/177 21.5%   55/245 22.4%   93/422 22.0% 
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The ROC curves are shown in Figure 1. From these and Table 2, we see that the GRNN ensemble makes a 
modest improvement on the individual classifiers. All tend to converge near the middle point. Above this threshold 
(i.e. preferring sensitivity to specificity), the linear regression classifier performs best among the individuals, and 
below (i.e. preferring specificity to sensitivity), the PNN performs best, while the ensemble provides the best across 
the board. 
  
Fig. 1. Oracle and PNN, SVM, regression ROC Curves 
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4. Conclusions 
This work provides a benchmark for predicting lung cancer recurrence within three years using only gender, age 
and TNM codes that are readily available in today’s clinical practice. Using leave-one-out cross validation, the 
GRNN ensemble classifier seems capable of error rates in the low 20% range for both false positives and false 
negatives. The data comprised 422 patients for whom gene expression microarray data are also avalable so the 
possibility of improved precision by adding gene signatures can be exploered. The 36-month threshold for 
recurrence was chosen because the cohorts were well balanced. We also plan to examine 60 months, as this may be 
a more clinically meaningful thershold. 
 
Work is still ongoing to prepare the microarray data for analysis: correcting for possible center effects 
(distributions of microarray values being different for the different research centers), and coarse feature reduction 
using significance analysis for microarays (SAM). Once the full data set is assembled, we plan to explore for gene 
signatures based upon microarray measurements that can be combined with these clinical measures to make further 
increases in the accuracy of recurrence prediction. Of course, any potentially useful findings will need independent 
verification in larger cohorts. 
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